ADHERENCE TO ORAL BISPHOSPHONATE THERAPY IN PATIENTS WITH OSTEOPOROSIS IN TIANJIN, CHINA

被引：0
|
作者：
Yu, Q. [1 ]
Wu, J. [1 ]
Wang, D. [2 ]
Liu, J. [3 ]
Jin, L. [4 ]
机构：
[1] Tianjin Univ, Tianjin 300072, Peoples R China
[2] Beijing Novartis Pharma Co Ltd, Beijing, Peoples R China
[3] Tianjin Med Insurance Res Assoc, Tianjin, Peoples R China
[4] Bur Human Resource & Social Secur, Tianjin, Peoples R China
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1145
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A226 / A226
页数：1
相关论文
共 50 条
  • [1] HEALTH CARE UTILIZATION AND EXPENDITURES OF OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATE IN TIANJIN, CHINA
    Yu, Q.
    Wu, J.
    Ma, F.
    Liu, J.
    Jin, L.
    Lin, M.
    Chang, J.
    VALUE IN HEALTH, 2013, 16 (07) : A560 - A560
  • [2] Adherence to bisphosphonate therapy for osteoporosis
    Nature Clinical Practice Rheumatology, 2007, 3 (2): : 66 - 66
  • [3] ADHERENCE TO BISPHOSPHONATE THERAPY FOR POSTMENOPAUSAL OSTEOPOROSIS IN BULGARIA
    Kuzmanova, S. I.
    Solakov, P. T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 374 - 374
  • [4] IMPROVED ADHERENCE TO ORAL BISPHOSPHONATE THERAPY
    Moore, A. E. B.
    Perera, D.
    Singh, P.
    Clarke, R. E. J.
    Hampson, G.
    Fogelman, I.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S689 - S690
  • [5] How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy
    Gold, Deborah T.
    Alexander, Ivy M.
    Ettinger, Mark P.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1143 - 1150
  • [6] Persistence with oral bisphosphonate therapy is high amongst patients followed in a DGH osteoporosis clinic
    Prowse, E
    McGetrick, D
    Thompson, V
    Hakim, AJ
    Doyle, DV
    RHEUMATOLOGY, 2005, 44 : I35 - I35
  • [7] Improving adherence to and persistence with oral therapy of osteoporosis
    M. L. Bianchi
    P. Duca
    S. Vai
    G. Guglielmi
    R. Viti
    C. Battista
    A. Scillitani
    S. Muscarella
    G. Luisetto
    V. Camozzi
    R. Nuti
    C. Caffarelli
    S. Gonnelli
    C. Albanese
    V. De Tullio
    G. Isaia
    P. D’Amelio
    F. Broggi
    M. Croci
    Osteoporosis International, 2015, 26 : 1629 - 1638
  • [8] Improving adherence to and persistence with oral therapy of osteoporosis
    Bianchi, M. L.
    Duca, P.
    Vai, S.
    Guglielmi, G.
    Viti, R.
    Battista, C.
    Scillitani, A.
    Muscarella, S.
    Luisetto, G.
    Camozzi, V.
    Nuti, R.
    Caffarelli, C.
    Gonnelli, S.
    Albanese, C.
    De Tullio, V.
    Isaia, G.
    D'Amelio, P.
    Broggi, F.
    Croci, M.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) : 1629 - 1638
  • [9] BISPHOSPHONATE THERAPY FOR OSTEOPOROSIS
    ATTIE, MF
    HOSPITAL PRACTICE, 1991, 26 (3A): : 87 - 90
  • [10] Factors Associated with Sub-optimal Adherence to Bisphosphonate Therapy among Patients with Postmenopausal Osteoporosis.
    DerSarkissian, Maral
    O'Malley, Cynthia
    Ferreira, Irene
    Silverman, Stuart
    Gold, Deborah
    Wagman, Rachel
    Grauer, Andreas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S196 - S196
12345